Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $118.6500 (-0.49%) ($118.5200 - $120.2700) on Fri. Jul. 14, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.42% (three month average) | RSI | 32 | Latest Price | $118.6500(-0.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.2% a day on average for past five trading days. | Weekly Trend | LGND declines -1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(53%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -0.71% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.71% (StdDev 1.42%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
Resistance Level | $119.64 | 5 Day Moving Average | $118.29(0.3%) | 10 Day Moving Average | $119.41(-0.64%) | 20 Day Moving Average | $119.64(-0.83%) | To recent high | -4.2% | To recent low | 13.7% | Market Cap | $1.907b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |